SEC Company Response from Progyny, Inc. (PGNY) (CIK 0001551306) (PGNY) — Oct 15, 2019
Progyny, Inc. (PGNY) (CIK 0001551306)
Date: Oct. 15, 2019 · CIK: 0001551306 · Accession: 0001104659-19-053877
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233965
Referenced dates: October 1, 2019
Letter
Nicole C. Brookshire
Via EDGAR and Overnight Courier
+1 617 937 2357
nbrookshire@cooley.com
October 15, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Information Technologies and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Pam Howell, Special Counsel
Ruairi Regan, Staff Attorney
Rufus Decker, Accounting Branch Chief
Steve Lo, Staff Accountant
Re:
Progyny, Inc.
Registration Statement on Form S-1
Filed September 27, 2019
File No. 333-233965
Ladies and Gentlemen:
On behalf of Progyny, Inc. (the “Company”), we are providing this letter in response to the comment (the “Comment”) received from the staff of the U.S. Securities and Exchange Commission’s Division of Corporation Finance (the “Staff”) by letter dated October 1, 2019 with respect to the Company’s Registration Statement on Form S-1, as filed with the Staff on September 27, 2019 (the “Registration Statement”). The Company is concurrently filing Amendment No.1 to the Registration Statement (the “Amended Registration Statement”), which includes changes that reflect the response to the Comment as well as certain other updates. For your convenience we have incorporated your Comment into this response letter in italics.
Form S-1 filed September 27, 2019
Exhibits
1. We note the three director nominees disclosed on page 111. Please file the consent of such individuals to be named director. See Rule 438 of Regulation C.
In response to the Staff’s Comment, the Company has filed such consents as Exhibits 99.1 through 99.3 to the Amended Registration Statement.
*
*
*
Cooley LLP 500 Boylston Street Boston, MA 02116-3736 t: (617) 937-2300 f: (617) 937-2400 cooley.com
Please contact me at (617) 937 2357 with any questions or further comments regarding our responses to the Staff’s Comments.
Sincerely,
/s/ Nicole C. Brookshire
Show Raw Text
CORRESP 1 filename1.htm Nicole C. Brookshire Via EDGAR and Overnight Courier +1 617 937 2357 nbrookshire@cooley.com October 15, 2019 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Information Technologies and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Pam Howell, Special Counsel Ruairi Regan, Staff Attorney Rufus Decker, Accounting Branch Chief Steve Lo, Staff Accountant Re: Progyny, Inc. Registration Statement on Form S-1 Filed September 27, 2019 File No. 333-233965 Ladies and Gentlemen: On behalf of Progyny, Inc. (the “Company”), we are providing this letter in response to the comment (the “Comment”) received from the staff of the U.S. Securities and Exchange Commission’s Division of Corporation Finance (the “Staff”) by letter dated October 1, 2019 with respect to the Company’s Registration Statement on Form S-1, as filed with the Staff on September 27, 2019 (the “Registration Statement”). The Company is concurrently filing Amendment No.1 to the Registration Statement (the “Amended Registration Statement”), which includes changes that reflect the response to the Comment as well as certain other updates. For your convenience we have incorporated your Comment into this response letter in italics. Form S-1 filed September 27, 2019 Exhibits 1. We note the three director nominees disclosed on page 111. Please file the consent of such individuals to be named director. See Rule 438 of Regulation C. In response to the Staff’s Comment, the Company has filed such consents as Exhibits 99.1 through 99.3 to the Amended Registration Statement. * * * Cooley LLP 500 Boylston Street Boston, MA 02116-3736 t: (617) 937-2300 f: (617) 937-2400 cooley.com Please contact me at (617) 937 2357 with any questions or further comments regarding our responses to the Staff’s Comments. Sincerely, /s/ Nicole C. Brookshire Nicole C. Brookshire cc: David Schlanger, Progyny, Inc. Mark Weeks, Cooley LLP Danielle Naftulin, Cooley LLP Alison Haggerty, Cooley LLP Deanna Kirkpatrick, Davis Polk & Wardwell LLP Yasin Keshvargar, Davis Polk & Wardwell LLP 2